School of Nursing

Permanent URI for this community

https://dspace.husson.edu/handle/20.500.14298/14

Browse

Browsing School of Nursing by Author "Bedi, Sarah"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Publication
    RACIALLY CONCORDANT CARE IN THE TREATMENT AND PREVENTION OF POSTPARTUM DEPRESSION IN AFRICAN AMERICAN WOMEN
    (2023-04-20) Nyambo, Leslie; Bedi, Sarah
    Postpartum depression (PPD) is part of the postpartum mood disorders experienced by women during the postpartum stage. It is characterized by feelings of extreme sadness, depressed mood, and loss of interest in formerly liked activities (Liu et al., 2015). Postpartum depression (PPD) is an ongoing issue notably for African American women. Ethnic, cultural, physiological, and demographic factors all play a role in the high prevalence of PPD in African American women compared to Caucasian women. Racially concordant and culturally aware peripartum care is crucial in the prevention, and treatment of PPD among African American women. Racially concordant care is one that is provided by a healthcare provider of the same racial or ethnic background as the patient (Shen et al., 2019). Its preference among minority populations is vastly due to the evidence that it greatly reduces instances of racism and bias, and increases patient satisfaction (Shen et al., 2019). The review method of the research was done using the PICO question, “In African American women, what is the effect of racially concordant perinatal care on the prevention and treatment of postpartum depression compared with discordant care within the postpartum period?” Using CINAHL Ultimate database, research of relevant literature was conducted using the following key terms: African American women, racially concordant care, and postpartum depression. Evidence-based practices such as racially concordant care and culturally-aware practices are important and should be implemented in nursing education as part of lowering health disparities. While racially concordant care for every African American mother might not be feasible, nurses that are informed and able to provide culturally sensitive screenings and postpartum care are crucial in decreasing the prevalence of postpartum depression in African American women.
  • Thumbnail Image
    Publication
    THE EFFECT OF THE JADA DEVICE ON POSTPARTUM HEMORRHAGE IN THE FIRST 24 HOURS
    (2025-04-17) Dow, Hazel; Bedi, Sarah
    Postpartum hemorrhage (PPH), an extreme loss of blood after birth, is the leading cause of maternal mortality worldwide. 80% of the time, this is due to uterine atony. The uterus is tired after birth and remains completely relaxed. A woman experiencing PPH can bleed out and die in minutes. In the past, controlling a PPH took hours utilizing traditional uterotonic medications and balloon-tamponade devices. Women frequently lost their uterus and were left with lifelong reproductive issues. However, now, we can solve this problem in as little as three minutes with the Jada Device. The Jada device was created in 2011 and FDA approved in 2020. It is a vacuum-tamponade device. It is inserted into the atonic uterus and suctions it, forcing it to clamp down and stopping the hemorrhage. A balloon-tamponade device is simply inflated and puts pressure on the walls of the uterus. The Jada device, however, treats the cause of the hemorrhage (uterine atony) instead of simply masking it, as the balloon device does. Right now, the Jada device is in 2,000 hospitals nationwide. However, there are over 6,000 in the nation total, not to mention the rest of the world. The risk for fatal PPH skyrockets in underdeveloped countries. This device needs to be put into every hospital in every country in the world. The Jada device is the solution for PPH when traditional uterotonics have failed. A balloon tamponade system is 87% effective, while the Jada system boasts 94% efficacy. Other options are surgical intervention, which is risky and likely not available in underdeveloped countries and rural areas. The Jada device can be used anywhere and by almost anyone.